SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Monsanto Co.
MTC 2.810+1.1%Jan 23 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Anthony Wong who wrote (952)1/21/1999 12:52:00 PM
From: jopawa  Read Replies (1) of 2539
 

Thursday January 21, 12:13 pm Eastern Time
Monsanto says considering more cost cuts
ST. LOUIS, Jan 21 (Reuters) - Life sciences company Monsanto Co. said Thursday that after taking steps to cut costs in the fourth quarter of 1998, it was considering more cost-savings plans that could result in future charges to earnings.

The company earlier reported pretax restructuring and special charges of $625 million in the fourth quarter, mainly to cover previously announced job cuts, to write down assets being sold and to dispose of nonstrategic assets and product lines.

''Our efforts in 1999 will be centered on continuing to grow strong base businesses like Roundup herbicide, integrating our newly acquired seed companies, commercializing new products like Celebrex arthritis treatment, and accelerating the development of our product pipeline,'' Monsanto's chairman and chief executive officer Robert Shapiro said in a statement.

Including charges, Monsanto posted a fourth quarter after-tax loss from continuing operations of $603 million, or $1.00 per diluted share, on sales of $2.1 billion. A year earlier, after-tax income from continuing operations was $5 million, or $0.01 per diluted share, also including charges. Fourth quarter 1997 sales were $1.8 billion.

Excluding charges, after-tax earnings from continuing operations were $27 million, or $0.05 per diluted share, compared with $55 million, or $0.09 per diluted share a year ago.

Monsanto shares were down 7/16 at 39-1/2 at midday on the New York Stock Exchange.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext